Invention Grant
- Patent Title: Acrylamide compounds as histamine H3 receptor ligands
- Patent Title (中): 丙烯酰胺化合物作为组胺H3受体配体
-
Application No.: US14419474Application Date: 2012-12-05
-
Publication No.: US09328092B2Publication Date: 2016-05-03
- Inventor: Ramakrishna Nirogi , Anil Karbhari Shinde , Adi Reddy Dwarampudi , Venkateswarlu Jasti
- Applicant: Suven Life Sciences Limited
- Applicant Address: IN
- Assignee: Suven Life Sciences Limited
- Current Assignee: Suven Life Sciences Limited
- Current Assignee Address: IN
- Agency: Schwegman, Lundberg & Woessner, P.A.
- Priority: IN3464/CHE/2012 20120823
- International Application: PCT/IN2012/000796 WO 20121205
- International Announcement: WO2014/030170 WO 20140227
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D211/46 ; C07C55/02
Abstract:
The present invention relates to novel acrylamide compounds of formula (I): wherein A, X, R1, and Y are as defined herein, and their pharmaceutically acceptable salts and process of their preparation. The compounds of formula (I) are useful in the treatment of various disorders that related to Histamine H3 receptors.
Public/Granted literature
- US20150218129A1 ACRYLAMIDE COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS Public/Granted day:2015-08-06
Information query
